Scientists test new Drug's hidden effects on heart, diabetes, and cholesterol pills

NCT ID NCT05064488

Summary

This early-stage study aimed to understand how a new drug called evobrutinib might change the way the body processes four other common medications: digoxin (for heart conditions), metformin (for diabetes), rosuvastatin (for cholesterol), and sumatriptan (for migraines). The study involved 40 healthy volunteers to measure drug levels in the blood and check for safety. The goal was to gather information to help doctors safely prescribe these drugs together in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Nuvisan GmbH

    Neu-Ulm, 89231, Germany

Conditions

Explore the condition pages connected to this study.